Vik Chopra
Stock Analyst at Wells Fargo
(1.86)
# 3,179
Out of 4,918 analysts
42
Total ratings
41.18%
Success rate
-6.72%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Maintains: Overweight | $246 → $199 | $130.89 | +52.04% | 3 | Jul 31, 2025 | |
| MASI Masimo | Maintains: Overweight | $205 → $190 | $152.72 | +24.41% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $11.95 | +8.79% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $67.75 | +10.70% | 2 | May 6, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $70 → $57 | $50.15 | +13.66% | 4 | May 1, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $70.81 | +5.92% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $14.12 | +34.56% | 2 | Feb 28, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $52.02 | +78.78% | 9 | Feb 21, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $20.60 | +1.94% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $8.49 | +53.21% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $13.57 | +40.01% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $26.04 | +203.38% | 3 | Feb 23, 2024 |
Align Technology
Jul 31, 2025
Maintains: Overweight
Price Target: $246 → $199
Current: $130.89
Upside: +52.04%
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $152.72
Upside: +24.41%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $11.95
Upside: +8.79%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $67.75
Upside: +10.70%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $50.15
Upside: +13.66%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $70.81
Upside: +5.92%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $14.12
Upside: +34.56%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $52.02
Upside: +78.78%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $20.60
Upside: +1.94%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $8.49
Upside: +53.21%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $13.57
Upside: +40.01%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $26.04
Upside: +203.38%